Acute myeloid leukemia: epidemiology and etiology (Q34571533)

3 August 2017

1 reference

title

Acute myeloid leukemia: epidemiology and etiology (English)

1 reference

3 August 2017

1 reference

1 reference

acute myeloid leukemia

1 reference

Barbara Deschler

1

1 reference

3 August 2017

Michael Lübbert

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

3 August 2017

1 reference

3 August 2017

volume

107

1 reference

3 August 2017

issue

9

1 reference

3 August 2017

page(s)

2099-2107

1 reference

3 August 2017

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Epidemiology and clinical burden of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Leukemias, myeloma, and other lymphoreticular neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Long-term trends in cancer mortality in the United States, 1930-1998.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Cancer prevalence in the UK: results from the EUROPREVAL study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Age and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Trends in leukemia incidence and survival in the United States (1973–1998)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Cancer mortality in the European Union, 1988-1997: The fall may approach 80,000 deaths a year

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Patterns of occurrence of the leukaemias

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Remission rate and survival in acute myeloid leukemia: impact of selection and chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Assessment of differences in patient populations selected for excluded from participation in clinical phase III acute myelogenous leukemia trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Management of acute myeloid leukemia in elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Late effects in survivors of infant leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Late effects of treatment in survivors of childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Osteoporosis in survivors of childhood malignancy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Cytogenetic and environmental factors in the etiology of the acute leukemias in adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Smoking and risk of acute myeloid leukemia: results from a Los Angeles County case-control study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.22233

1 reference

7 January 2021

Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Birth characteristics and leukemia in young children

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Acute promyelocytic leukaemia in patients originating in Latin America is associated with an increased frequency of the bcr1 subtype of the PML/RARalpha fusion gene.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

The epidemiology of acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Cytogenetic analysis in the diagnosis of acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Karyotype and age in acute myeloid leukemia. Are they linked?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Population-based demographic study of karyotypes in 1709 patients with adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

A single-center population-based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotypic features in relation to morphology, age and gender

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

The roles of FLT3 in hematopoiesis and leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

CYP1A1*2B (Val) allele is overrepresented in a subgroup of acute myeloid leukemia patients with poor-risk karyotype associated with NRAS mutation, but not associated with FLT3 internal tandem duplication.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Acute myelogenous leukemia after exposure to strontium-89 for the treatment of adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Long-term evaluation of 164 patients with essential thrombocythaemia treated with pipobroman: occurrence of leukaemic evolution

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Review of epidemiologic evidence on benzene and lymphatic and hematopoietic cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Friend virus-induced erythroleukemia and the multistage nature of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Association of acute parvovirus B19 infection with new onset of acute lymphoblastic and myeloblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Poor survival of treatment-related acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Cytogenetics of secondary myelodysplasia (sMDS) and acute nonlymphocytic leukemia (sANLL)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Further characterization of complex chromosomal rearrangements in myeloid malignancies: spectral karyotyping adds precision in defining abnormalities associated with poor prognosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Increase therapy-related leukemia secondary to breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22233

7 January 2021

Identifiers

DOI

10.1002/CNCR.22233

1 reference

3 August 2017

1 reference